Allezoe (ALZM) Announces New Management for SureScreen Medical

BOCA RATON, FLORIDA--(Marketwire - March 15, 2012) - Allezoe Medical Holdings ALZM today announced that Caroline Pinell has agreed to join the Company on a full time basis and has been named as the President and CEO of SureScreen Medical, Inc., a wholly-owned subsidiary of the Company. She will also serve as President and Chief Operating Officer for Allezoe Medical and will remain as a member of the Board of Directors. SureScreen recently acquired the exclusive license to develop and market patent pending, advanced, "see and treat" diagnostic technology for HPV, the world's leading sexually transmitted infection (STI). Under the terms of the license, SureScreen will develop and market products worldwide using the technology in return for a fixed royalty to AVM Licensing Corp., commencing on sales of products using the technology.

Caroline Pinell has been a high level operations consultant to a wide range of healthcare industry clients, including hospitals, independent physician associations, physician groups and networks, medical practices, attorneys, and Medicare and Medicaid health plans. Pinell has extensive experience developing and implementing strategic business plans and focused marketing measures for healthcare organizations, as well as overseeing healthcare compliance and licensing. Ms. Pinell attended the MD program at the University of Texas Health Science Center and earned a law degree from the South Texas College of Law.

From 2005 to the present, she has been an Independent Healthcare Consultant, serving as a as a high level healthcare operations consultant to various clients, including Hospitals, Independent Physician Associations, Physician Groups and Networks, Medical Practices, Attorneys, and various Medicare and Medicaid Health Plans.

From 2008 to 2009, she was President and CEO of ATRIO Health Plans, a Medicare Advantage (MA-PD) Plan located in Oregon. It services three counties including Douglas, Coos, and Klamath Counties with expansion plans in place for Washington County. The Plan covers approximately 4500 lives with significant growth expected over the next three years. The Provider Network included 99% of all providers in each the counties it currently services.

From 2006 to 2008, she was Vice President and Executive Director of Physician Relations, Business development and Managed Care at HCA-Bayshore Medical Center, a 463 Bed acute care community hospital serving Pasadena, Texas and its surrounding areas. The Medical Staff includes over 400 physicians in various specialties including internal medicine, cv surgery, neurosurgery, oncology, and critical care intensivists.

From 2005 to 2006, she was Chief Operating Officer of IntegraNet Physicians Resources, Inc., a privately owned independent physician association with a citywide provider network that exceeds 750 physicians in the Houston area. It currently houses credentialing, contracting, provider relations, and claims management departments. The company holds contracts with four Health Plans that represent multiple Medicare and Medicaid products.

From 2000 to 2005, she was Vice President of Operations for Primary Medical Care, Memorial Clinical Associates and MCA Research, three affiliated healthcare operations in the Houston, Texas area.

Michael Gelmon, CEO of Allezoe Medical Holdings, stated: "We are fortunate to have obtained the fill time services of a medical and legal professional of the caliber of Caroline Pinell to join us and to manage our SureScreen Medical subsidiary. We are confident that the HPV technology licensed by SureScreen will be successfully developed and brought to the market with Caroline Pinnell's guidance."

FORWARD LOOKING STATEMENT

Certain statements contained herein and subsequent oral statements made by and on behalf of ALZM may contain "forward looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward looking statements are identified by words such as "intends", "anticipates", "believes", "expects", and "hopes" and includes, without limitation, statements regarding ALZM's plan of business operations, product research and development activities, anticipated revenues and expenses and potential contractual arrangements and obligations. Also, our management may make forward-looking statements orally to investors, analysts, the media and others. Any statements made in this news release about an action, event or development, are forward-looking statements. Such statements are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties. Such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the Company. These risks and others are included from time to time in documents we file with the Securities and Exchange Commission, including but not limited to, its Form 10-Ks, Form 10-Qs and Form 8-Ks. Other unknown or unpredictable factors also could have material adverse effects on our future results. Accordingly, you should not place undue reliance on these forward-looking statements. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it can give no assurance that its forward-looking statements will prove to be correct. Investors are cautioned that any forward-looking statements are not guarantees of future performance and actual results or developments may differ materially from those projected. The forward-looking statements in this press release are made as of the date hereof. The Company undertakes no obligation to update or correct its own forward-looking statements, except as required by law or those prepared by third parties that are not paid by the Company. The Company's SEC filings are available at http://www.sec.gov.